Mesirow Financial Investment Management - Fixed Income’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-29,010
Closed -$435K 129
2017
Q1
$435K Buy
+29,010
New +$435K 0.03% 113